ISPOR Europe 2026

Malina Müller - Co-Chair, Head of Health Economics, WifOR Institute, Germany Sandra Nestler-Parr - Co-Chair, SVP Value & Patient Access, BioCryst Pharmaceuticals, BioCryst Ireland Limited, Ireland Rasmus Prior Gjesing - Co-Chair, Regional Adviser, Access to Medicines & Health Products (AMP), WHO Europe, Denmark Hussain Al-Omar - Member, Professor of Pharmacoeconomics and Pharmaceutical Policy, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Saudi Arabia Abeer Al Rabayah - Member, Head, Center for Drug Policy and Technology Assessment, King Hussein Cancer Foundation and Center, Jordan Bryan Bennett - Member, Head of Patient Centered Outcomes, Senior Director, Jazz Pharma, United Kingdom Sandrine Bourguignon - Member, Global Market Access and Data Generation Lead, Ziwig, France Adam Day - Member, Director, Ossomed, United Kingdom Manuela Deidda - Member, Senior Research Fellow in Health Economics, University of Glasgow, Scotland Lorna Dunning - Member, Associate Director – Technology Appraisals, NICE, United Kingdom Diána Elmer - Member, Senior Lecturer, Institute for Health Insurance, University of Pécs, Hungary Gihan Hamdy El-sisi - Member, Managing Director, HTA Office (Technology Appraisal), Middle East and North Africa, Egypt Salah Ghabri - Member, Senior Scientific Referent in Health Economics, Department of Medical Evaluation, French National Authority for Health, France Anders Gorst-Rasmussen - Member, Head of Launch Evidence Generation & Orchestration, Novo Nordisk, Denmark Matt Griffiths - Member, Value and Access Director, Costello Medical, United Kingdom Rita Faria - Member, Lead Health Economics, Astellas Pharma Europe Ltd, United Kingdom Carla Fernández-Barceló - Member, HEOR Manager, Novartis, Ireland Kirk Geale - Member, CEO and Board Member, Quantify Research & Head of RWE, Athagoras Group, Sweden Marieke Heisen - Member, Director of Research and Patient Evidence, Patvocates & European Patient Advocacy Institute (EPAI), the Netherlands Anke-Peggy Holtorf - Member, Managing Director, Health Outcomes Strategies, Switzerland Seamus Kent - Member, Assistant Professor, Erasmus University Rotterdam, the Netherlands Irina Kinchin - Member, Research Assistant Professor, Trinity College Dublin, Ireland Katarzyna Kolasa - Member, Director Digital Health Center, Professor of Health Economics, Kozminski University, Poland Dawn Lee - Member, Associate Professor, PenTAG, University of Exeter, United Kingdom Samuel Llewellyn - Member, Director, Patient Centered Research, Vitaccess, United Kingdom Ka Keat Lim - Member, Lecturer in Health Economics, Queen Mary University of London, United Kingdom Borislava Mihaylova - Member, Professor of Health Economics, Health Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, United Kingdom & Senior Health Economist, Health Economics Research Centre, University of Oxford, United Kingdom Daniel Prieto-Alhambra - Member, Professor of Pharmaco- and Device Epidemiology, University of Oxford, Centre for Statistics in Medicine, NDORMS, United Kingdom Katja Rudell - Member, Vice President, Kielo Research, United Kingdom Angela Rylands - Member, Global Head - Patient Centered Outcomes, Kyowa Kirin International plc., United Kingdom Fatima Salih - Member, Scientific Advisor, NICE, United Kingdom Marie-Therese Estephan Sawaya - Member, Head of Market Access, GEM and Levant, Abbott EPD, Lebanon Martin Scott - Member, Scientific Director, Numerus, Germany Sheela Upadhyaya - Member, Life Sciences Consultant - Rare Diseases, Openflex Ltd, United Kingdom Leonor Varela - Member, Public Health and Preventive Medicine, University of Santiago de Compostela, Spain Steffen Wahler - Member, CEO, St. Bernward GmbH, Germany